# RITONAVIR
> **ANDA203759** · Abbreviated New Drug Application (Generic) · Sponsor: CIPLA · Approved 2022-05-10
## Drug
- **FDA Application Number:** ANDA203759
- **Application type:** Abbreviated New Drug Application (Generic)
- **Brand name:** RITONAVIR
- **Generic name:** Ritonavir
- **Active ingredients:** RITONAVIR
- **Dosage form:** TABLET
- **Route:** ORAL
- **Marketing status:** Prescription
- **Sponsor:** CIPLA
- **First approval:** 2022-05-10
## Source
- [Drugs@FDA application overview](https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=203759)
---
*MORVS · CC0 1.0*